CHARACTERIZATION OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA ENTERING REMISSION IN A ROMIPLOSTIM BONE MARROW STUDY

被引：0
|
作者：
Janssens, A. [1 ]
Cervinek, L. [2 ]
Tejeda Romero, M. [3 ]
Wang, X. [4 ]
Eisen, M. [4 ]
机构：
[1] Univ Hosp Leuven, Dept Hematol, Campus Gasthuisberg, Leuven, Belgium
[2] Masaryk Univ, Univ Hosp, Brno, Czech Republic
[3] Hosp Juarez Mexico, Mexico City, DF, Mexico
[4] Amgen Inc, Thousand Oaks, CA USA
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P03
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [31] The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia
    Cooper, Nichola
    Terrinoni, Ilaria
    Newland, Adrian
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (05) : 291 - 298
  • [32] RESULTS FROM A PHASE IV OPEN-LABEL STUDY EVALUATING CHANGES IN BONE MARROW MORPHOLOGY IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS RECEIVING ROMIPLOSTIM: ANALYSIS OF THE 1-YEAR ROMIPLOSTIM COHORT
    Rodeghiero, F.
    George, J.
    Rummel, M.
    Anderson, D.
    Chong, B.
    Boda, Z.
    Hellmann, A.
    Wang, X.
    Woodard, P.
    HAEMATOLOGICA, 2012, 97 : 425 - 425
  • [33] Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim
    Hanny Al-Samkari
    Elizabeth M. Van Cott
    David J. Kuter
    Annals of Hematology, 2019, 98 : 581 - 588
  • [34] Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim
    Al-Samkari, Hanny
    Van Cott, Elizabeth M.
    Kuter, David J.
    ANNALS OF HEMATOLOGY, 2019, 98 (03) : 581 - 588
  • [35] Bone marrow examination in patients with immune thrombocytopenia: is there anything different in older patients?
    Gunduz, Eren
    Kivanc, Banu Kara
    Arik, Deniz
    Isiksoy, Serap
    Bal, Cengiz
    Akay, Olga Meltem
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (02) : 157 - 160
  • [36] BONE MARROW EXAMINATION IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: IS THERE ANYTHING DIFFERENT IN OLDER PATIENTS?
    Gunduz, E.
    Kivanc, B. Kara
    Karagulle, M.
    Arik, D.
    Isiksoy, S.
    Bal, C.
    Akay, O. M.
    HAEMATOLOGICA, 2014, 99 : 772 - 772
  • [37] Multicenter, prospective study to evaluate the efficacy of biweekly romiplostim administration in patients with immune thrombocytopenia
    Park, Silvia
    Yoon, Sung Soo
    Lee, Jung Hee
    Park, Joon Seong
    Jang, Jun Ho
    Lee, Jong Wook
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (01) : 44 - 52
  • [38] An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim
    Stasi, Roberto
    Newland, Adrian
    Godeau, Bertrand
    Priego, Victor
    Viallard, Jean-Francois
    Fernandez, Maria Fernanda Lopez
    Jia, Catherine
    Lopez, Angela
    BLOOD, 2013, 122 (21)
  • [39] Efficacy and safety of romiplostim in adult Iraqi patients with refractory immune thrombocytopenia
    Jumaa, Ali
    Saleh, Tareq
    Khalaf, Asaad
    Abbas, Mohammed
    IRAQI JOURNAL OF HEMATOLOGY, 2020, 9 (02) : 92 - 96
  • [40] ROMIPLOSTIM IN SPLENECTOMIZED (SPLNX) AND NONSPLENECTOMIZED (NONSPLNX) PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Cines, D.
    Wasser, J.
    Rodeghiero, F.
    Chong, B.
    Steurer, M.
    Provan, D.
    Lyons, R.
    Garcia Chavez, J.
    Carpenter, N.
    Wang, X.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 194 - 194
12345